Enteric Pathogen | Prevalence (95% Confidence Interval) | ||||
---|---|---|---|---|---|
Total enrolled | Boys 1–15 years | Men 16–81 years | Girls 1–15 years | Women 16–81 years | |
Total Samples | 269 | 54 | 83 | 47 | 85 |
At least one pathogen positive | 83.6% (78.7–87.6) | 85.2% (72.7–92.5) | 83.1% (73.3–89.8) | 89.4% (76.4–95.6) | 80.0% (70.0–87.3) |
Bacteria | 73.9% (68.4–78.9) | 68.5% (54.7–79.7) | 75.9% (65.4–84.0) | 78.7% (64.4–88.3) | 72.9% (62.4–81.4) |
Toxigenic Vibrio cholerae | 38.3% (32.6–44.3) | 25.9% (15.8–39.5) | 51.8% (41.0–62.5) | 38.3% (25.3–53.2) | 32.9% (23.7–43.7) |
Enterotoxigenic E. coli | 35.7% (30.2–41.6) | 40.7% (28.3–54.5) | 30.1% (21.1–41.0) | 38.3% (25.3–53.2) | 36.5% (26.8–47.3) |
Campylobacter | 16.7% (12.7–21.7) | 27.8% (17.3–41.4) | 10.8% (5.7–19.7) | 29.8% (18.3–44.6) | 8.2% (3.9–16.4) |
Shigella | 16.0% (12.1–20.9) | 24.1% (14.3–37.5) | 14.5% (8.3–23.9) | 23.4% (13.2–37.9) | 8.2% (3.9–16.4) |
Salmonella | 3.7% (2.0–6.8) | 3.7% (0.9–14.0) | 2.4% (0.6–9.4) | 4.3% (1.0–16.0) | 4.7% (1.8–12.0) |
Escherichia coli O157 | 2.5% (1.3–5.4) | 1.9% (0.2–12.5) | 2.5% (0.6–9.5) | 6.4% (2.0–18.5) | 1.2% (0.1–8.1) |
Clostridium difficile | 1.9% (0.8–4.4) | 1.9% (0.2–12.5) | – | 2.1% (0.3–14.3) | 3.5% (1.1–10.5) |
Shiga Toxin-producing E. coli | 0.7% (0.2–2.9) | – | – | 2.1% (0.3–14.3) | 1.2% (0.02–8.1) |
Yersinia enterocolitica | – | – | – | – | – |
Viruses | 2.2% (1.0–4.9) | 5.6% (1.8–16.2) | – | 2.1% (0.3–14.3) | 2.4% (0.6–9.1) |
Adenovirus 40/41 | 1.1% (0.4–3.4) | 1.8% (0.2–12.5) | – | 2.1% (0.3–14.3) | 1.2% (0.2–8.1) |
Norovirus GI/GII | 0.7% (0.2–2.9) | 18.5% (0.2–12.5) | – | – | 1.2% (0.2–8.1) |
Rotavirus A | 0.4% (0.1–2.6) | 1.9% (0.2–12.5) | – | – | – |
Parasites | 27.5% (22.5–33.2) | 35.2% (23.5–49.0) | 26.5% (18.0–37.2) | 29.8% (18.3–44.6) | 22.4% (14.6–32.6) |
Cryptosporidium | 27.5% (22.5–33.2) | 35.2% (23.5–49.0) | 26.5% (18.0–37.2) | 29.8% (18.3–44.6) | 22.4% (14.6–32.6) |
Entamoeba histolytica | – | – | – | – | – |
Pathogen Diversity | |||||
No pathogens | 16.4% (12.4–21.3) | 14.8% (7.5–27.3) | 16.9% (10.2–26.7) | 10.6% (4.4–23.6) | 20.0% (12.7–30.0) |
Single pathogen | 38.3% (32.6–44.3) | 35.2% (23.5–49.0) | 41.0% (30.8–52.0) | 21.3% (11.6–35.6) | 47.1% (36.6–57.8) |
2 pathogens | 25.6% (20.8–31.2) | 18.5% (10.1–31.5) | 26.5% (18.0–37.2) | 36.2% (23.5–51.1) | 23.5% (15.6–33.8) |
3 pathogens | 14.9% (11.1–19.7) | 22.2% (12.9–35.5) | 12.0% (6.5–21.1) | 23.5% (13.2–37.9) | 8.2% (3.9–16.4) |
4 pathogens | 3.7% (2.0–6.8) | 7.4% (2.7–18.5) | 3.6% (1.2–10.8) | 6.4% (2.0–18.5) | – |
5 pathogens | 0.7% (0.2–2.9) | – | – | 2.1% (0.3–1.4) | 1.2% (0.2–8.1) |
6 pathogens | – | – | – | – | – |
7 pathogens | – | – | – | – | – |
8 pathogens | 0.4% (0.1–2.6) | 1.9% (0.2–12.5) | – | – | – |